EP2661263
USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.1.2012EP published:
14.4.2021EP application number:
12700294.7
EPO information:
European Patent Register
Max expiry date:
2.1.2032
Title:
USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY
Timeline
Today
3.1.2012EP application
14.4.2021EP Publication
Owner
Name:
GW Pharma LimitedAddress:
Sovereign House, Histon Cambridge CB24 9BZ, GB
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, JP
Inventor
Name:
WHALLEY, BenjaminAddress:
Reading RG6 6AP, GB
Name:
WILLIAMS, ClaireAddress:
Reading RG6 6AP, GB
Name:
STEPHENS, GaryAddress:
Reading RG6 6AP, GB
Priority
Number:
201100043Date:
4.1.2011Country:
GB
Classification
Categories:
A61K 31/05, A61K 31/19, A61K 31/4015, A61P 25/08